ADIPOQ and metabolic dysfunction-associated steatotic liver disease: No matter obese or not, adiponectin is a biomarker for NAFLD subjects indicating the progression to steatohepatitis in a biopsy proven study [29] and the development of NAFLD in a Korea cohort [30].